Anti-Polyoma virus,Medium T antigen抗体[PyMT] (ab15085)


  • 产品名称
    Anti-Polyoma virus,Medium T antigen抗体[PyMT]
  • 描述
    大鼠单克隆抗体[PyMT] to Polyoma virus,Medium T antigen
  • 宿主
  • 经测试应用
    适用于: IP, ICC/IF, WBmore details
  • 免疫原

    Synthetic peptide (N terminal).

  • 常规说明

    Binds medium T antigen only, allows isolation of viral T antigens.



Our Abpromise guarantee covers the use of ab15085 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IP Use at an assay dependent dilution.
ICC/IF Use at an assay dependent dilution.
WB Use at an assay dependent concentration.


  • 相关性
    Middle T antigen (MT) is a 421-amino-acid protein associated with membranes and underlying cytoskeletal elements, and is associated with a tyrosine-specific protein kinase activity. It is the principal oncoprotein of polyomavirus that is necessary and often sufficient for transformation in vitro. MT delivered as a transgene or a retrovirus can induce tumors in a wide variety of tissues. Polyomavirus (PyV) is a small, double-stranded, closed-circular-DNA virus with an approximately 5-kb genome divided into two roughly equal regions. The late transcripts produce the viral capsid proteins, whereas the early region encodes three so-called tumor (T) antigens that are important for both productive infection and transformation.
  • 细胞定位
    Cytoplasmic location in cells infected with virus.
  • 别名
    • Middle T antigen antibody
    • MT AG antibody
    • MT antibody
    • Polyoma virus middle t antigen antibody


This product has been referenced in:
  • Kim J  et al. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Res 76:6424-6435 (2016). ICC/IF . Read more (PubMed: 27569213) »
  • Roy A  et al. Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma. PLoS One 11:e0156151 (2016). Read more (PubMed: 27223472) »

See all 9 Publications for this product


Thank you for contacting us.

I am sorry to hear you are experiencing difficulties with one of our products. We take product complaints very seriously, and investigate every product that we feel may not be performing correctly.

I am at...

Read More

I am sorry for the delay in getting back to you in regards to the protocol used with the Anti-Polyoma virus, Medium T antigen antibody [PyMT] (ab15085).
I can now provide some further guidance in how I would suggest using the antibody in IHC. From...

Read More

Thank you for contacting us yesterday in regards to the Anti-Polyoma virus, Medium T antigen antibody [PyMT] (ab15085).
Unfortunately, as we discussed over the phone, this antibody has as yet not been used in IHC to our knowledge. This does not me...

Read More

Thank you very much for your patience.
We can confirm that the antibody is specific to Medium T form only. We have no cross reactivity data regarding small and large T forms. The clone specific publication data show the antibody should not be cross...

Read More

Thank you for contacting us.

I am afraid ab15085 has not been tested in IHC, and therefore we cannot guarantee it will work in this application. You may find useful our online protocols about IHC in order to optimise the staining:


Read More

Thank you for your email and patience. I presently have concerns about the suitability of this antibody in Western blotting and have removed the application from our online datasheet. We haven't received any other complaints, but the originator of this...

Read More

Thank you for your enquiry. More details about this antibody can be found in the following references: Dilworth SM & Griffin BE Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A 79:1059-63 (1982). PubMed: 6175960 ...

Read More